Greater than 1.6 million individuals use weight reduction remedy throughout the UK
Thousands and thousands of individuals use weight reduction remedy (Picture: Getty)
Hundreds of individuals utilizing weight reduction injections might see a change to their jab after a brand new ruling by a well being physique. It’s believed greater than 1.6 million individuals within the UK use weight reduction medication equivalent to Wegovy and Mounjaro.
Now the Medicines and Healthcare merchandise Regulatory Company (MHRA) has backed a change in the way in which Wegovy is run. Ranging from Tuesday, April 14, a brand new single-dose 7.2mg semaglutide (Wegovy) pen will likely be out there to deal with grownup sufferers with weight problems, who’ve a Physique Mass Index (BMI) of 30kg/m² or larger.
We use your sign-up to supply content material in methods you’ve got consented to and to enhance our understanding of you. This will likely embrace adverts from us and third events primarily based on our understanding. You’ll be able to unsubscribe at any time. Learn our Privateness Coverage
The transfer will help grownup sufferers with weight problems by offering the choice of a single-dose injection to obtain the utmost weekly dose for weight reduction and weight administration. The 7.2mg dose is run by way of one injection. The newly authorised machine consists of an computerized dosing mechanism with a built-in needle which is enclosed inside a needle cowl and locks after use.
Nevertheless, the change doesn’t apply to chubby sufferers with a BMI of lower than 30kg/m² utilizing Wegovy for weight administration. It additionally excludes sufferers utilizing Wegovy to decrease their threat of significant coronary heart issues.
This determination follows the January 2026 authorisation of the 7.2mg most weekly dose. This required three 2.4mg doses administered on the identical day utilizing the usual 2.4mg pen, studies the Mirror.
Producer, Novo Nordisk, has welcomed the choice and stated it’s now working with healthcare companions and suppliers to help the UK rollout of the brand new machine. It stated inventory can be anticipated to be out there in 4 to 6 weeks.
Sebnem Avsar Tuna, UK Basic Supervisor, Novo Nordisk U, stated: “The approval of this new single‑dose machine gives a further administration possibility for individuals within the UK who’re prescribed the 7.2 mg as soon as weekly upkeep dose of Wegovy. We welcome the MHRA’s determination and can proceed to work with healthcare professionals and companions to help its introduction in step with native prescribing preparations.”
When sufferers begin utilizing Wegovy, the beginning dose is 0.25mg per week, which will likely be step by step elevated each 4 weeks as required and prescribed by the suitable healthcare skilled. The utmost dose is 7.2mg per week.
The MHRA has confirmed that, as with all medicines, it’ll proceed to observe the protection and efficacy of Wegovy. It added: “Anybody who suspects they’re having a aspect impact from this medication are inspired to speak to their physician, pharmacist or nurse and report it on to the Yellow Card scheme, both by way of the web site or by looking out the Google Play or Apple App shops for MHRA Yellow Card.
Leave a Reply